The new variant of Salmonella genomic island 1 (SGI1-V) from a Proteus mirabilis French clinical isolate harbours blaVEB-6 and qnrA1 in the multiple antibiotic resistance region

New variant Salmonella genomic island 1-U in Proteus mirabilis clinical and food isolates from South China

(2011) Shuilian Bi et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

European clinical isolate of Proteus mirabilis harbouring the Salmonella genomic island 1 variant SGI1-O

(2010) Benoît Doublet et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

ISCR2, Another Vehicle for blaVEB Gene Acquisition

(2009) L. Poirel et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

A blaVEB-1 Variant, blaVEB-6, Associated with Repeated Elements in a Complex Genetic Structure

(2009) Z. Zong et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Novel Insertion Sequence- and Transposon-Mediated Genetic Rearrangements in Genomic Island SGI1 of Salmonella enterica Serovar Kentucky

(2008) B. Doublet et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Complete nucleotide sequence of pKP96, a 67 850 bp multiresistance plasmid encoding qnrA1, aac(6′)-Ib-cr and blaCTX-M-24 from Klebsiella pneumoniae

(2008) Ping Shen et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Increase in  -lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type  -lactamases

(2008) L. M. Aragon et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY